Apellis Pharmaceuticals
Platform of novel therapeutic compounds for the treatment of autoimmune diseases.
Launch date
Employees
Market cap
$4.6b
Enterprise valuation
$4.7b (Public information from Sep 2024)
Share price
$32.51 APLS
Waltham Massachusetts (HQ)
Authorizing premium user...